Neuroendocrinology
Original Paper
Phosphodiesterase 10A in the Rat Pineal Gland: Localization, Daily and Seasonal Regulation of Expression and Influence on Signal TransductionSpiwoks-Becker I.a · Wolloscheck T.b · Rickes O.b · Kelleher D.K.b · Rohleder N.d · Weyer V.c · Spessert R.bInstitutes of aMicroanatomy and Neurobiology, bFunctional and Clinical Anatomy and cMedical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University, Mainz, and dDepartment of Oral and Maxillofacial Surgery, Technische Universität, München, München, Germany
|
|
Neuroendocrinology 2011;94:113–123
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
First-Page Preview
Received: October 22, 2010
Accepted: March 05, 2011
Published online: April 07, 2011
Issue release date: September 2011
Number of Print Pages: 11
Number of Figures: 6
Number of Tables: 1
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Abstract
The cyclic nucleotide phosphodiesterase 10A (PDE10A) is highly expressed in striatal spiny projection neurons and represents a therapeutic target for the treatment of psychotic symptoms. As reported previously [J Biol Chem 2009; 284:7606–7622], in this study PDE10A was seen to be additionally expressed in the pineal gland where the levels of PDE10A transcript display daily changes. As with the transcript, the amount of PDE10A protein was found to be under daily and seasonal regulation. The observed cyclicity in the amount of PDE10A mRNA persists under constant darkness, is blocked by constant light and is modulated by the lighting regime. It therefore appears to be driven by the master clock in the suprachiasmatic nucleus (SCN). Since adrenergic agonists and dibutyryl-cAMP induce PDE10A mRNA, the in vitro clock-dependent control of Pde10a appears to be mediated via a norepinephrine → β-adrenoceptor → cAMP/protein kinase A signaling pathway. With regard to the physiological role of PDE10A in the pineal gland, the specific PDE10A inhibitor papaverine was seen to enhance the adrenergic stimulation of the second messenger cAMP and cGMP. This indicates that PDE10A downregulates adrenergic cAMP and cGMP signaling by decreasing the half-life of both nucleotides. Consistent with its effect on cAMP, PDE10A inhibition also amplifies adrenergic induction of the cAMP-inducible gene arylalkylamine N-acetyltransferase (Aanat) which codes the rate-limiting enzyme in pineal melatonin formation. The findings of this study suggest that Pde10a expression is under circadian and seasonal regulation and plays a modulatory role in pineal signal transduction and gene expression.
© 2011 S. Karger AG, Basel
Related Articles:
References
- Bailey MJ, Coon SL, Carter DA, et al: Night/day changes in pineal expression of >600 genes: central role of adrenergic/cAMP signalling. J Biol Chem 2009;284:7606–7622.
- Goldman BD: The circadian timing system and reproduction in mammals. Steroids 1999;64:679–685.
- Goldman BD: Mammalian photoperiodic system: formal properties and neuroendocrine mechanisms of photoperiodic time measurement. J Biol Rhythms 2001;16:283–301.
- Schwartz WJ, de la Iglesia HO, Zlomanczuk P, Illnerová H: Encoding le quattro stagioni within the mammalian brain: photoperiodic orchestration through the suprachiasmatic nucleus. J Biol Rhythms 2001;16:302–311.
- Hastings MH, Maywood ES, Reddy AB: Two decades of circadian time. J Neuroendocrinol 2008;20:812–819.
- Pévet P, Agez L, Bothorel B, Saboureau M, Gauer F, Laurent V, Masson-Pévet M: Melatonin in the multi-oscillatory mammalian circadian world. Chronobiol Int 2006;23:39–51.
- Møller M, Baeres FM: The anatomy and innervation of the mammalian pineal gland. Cell Tissue Res 2002;309:139–150.
- Simonneaux V, Ribelayga C: Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 2003;55:325–395.
- Gupta BBP, Spessert R, Vollrath L: Molecular components and mechanism of adrenergic signal transduction in mammalian pineal gland: regulation of melatonin synthesis. Indian J Exp Biol 2005;43:115–149.
- Klein DC, Coon SL, Roseboom PH, Weller JL, Bernard M, Gastel JA, Zatz M, Iuvone PM, Rodriguez IR, Bégay V, Falcón J, Cahill GM, Cassone VM, Baler R: The melatonin rhythm-generating enzyme: molecular regulation of serotonin N-acetyltransferase in the pineal gland. Recent Prog Horm Res 1997;52:307–357.
- Ho AK and Chik CL: Modulation of Aanat gene transcription in the rat pineal gland. J Neurochem 2010;112:321–331.
-
Chik Cl, Liu QY, Li B, Karpinski E, Ho AK: cGMP inhibits L-type Ca2+ channel currents through protein phosphorylation in rat pinealocytes. J Neurosci 1995;1 5:3104–3109.
- Engel L, Gupta BBP, Lorenzkowski V, Heinrich B, Schwerdtle I, Gerhold S, Holthues H, Vollrath L, Spessert R: Fos-related antigen 2 (Fra-2) memorizes photoperiod in the rat pineal gland. Neuroscience 2005;132:511–518.
- Ho AK, Price DM, Terriff D, Chik CL: Timing of mitogen-activated protein kinase (MAPK) activation in the rat pineal gland. Mol Cell Endocrinol 2006;252:34–39.
- Minneman KP, Iversen LL: Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity. Nature 1976;260:59–61.
- Epplen JT, Kaltenhäuser H, Engel W, Schmidtke J: Patterns of cyclic AMP phosphodiesterases in the rat pineal gland: sex differences in diurnal rhythmicity. Neuroendocrinology 1982;34:46–54.
- Kim JS, Bailey MJ, Ho AK: Daily rhythm in pineal phosphodiesterase (PDE) activity reflects adrenergic/3′,5′-cyclic adenosine 5′-monophosphate induction of the PDE4B2 variant. Endocrinology 2007;148:1475–1485.
- Fujishige K, Kotera J, Michibata H, Yuasa K, Takebayashi S, Okumura K, Omori K: Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J Biol Chem 1999;274:18438–18445.
- Loughney K, Snyder PB, Uher L, Rosman GJ, Ferguson K, Florio VA: Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide phosphodiesterase. Gene 1999;234:109–117.
- Soderling SH, Bayuga SJ, Beavo JA: Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci USA 1999;96:7071–7076.
- Coskran TM, Morton D, Menniti FS, Adamowicz WO, Kleiman RJ, Ryan AM, Strick CA, Schmidt CJ, Stephenson DT: Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J Histochem Cytochem 2006;54:1205–1213.
- Fujishige K, Kotera J, Omori K: Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A. Eur J Biochem 1999;266:1118–1127.
- Seeger TF, Bartlett B, Coskran TM, Culp JS, James LC, Krull DL, Lanfear J, Ryan AM, Schmidt CJ, Strick CA, Varghese AH, Williams RD, Wylie PG, Menniti FS: Immunohistochemical localization of PDE10A in the rat brain. Brain Res 2003;985:113–126.
- Xie Z, Adamowicz WO, Eldred WD, Jakowski AB, Kleiman RJ, Morton DG, Stephenson DT, Strick CA, Williams RD, Menniti FS: Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase. Neuroscience 2006;139:597–607.
- Strick CA, James LC, Fox CB, Seeger TF, Menniti FS, Schmidt CJ: Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A. Neuropharmacology 2010;58:444–451.
- Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, Williams RD, Stock JL, McNeish JD, Strick CA, Menniti FS, Schmidt CJ: Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 2006;51:374–385.
- Siuciak JA, McCarthy SA, Chapin DS, Martin AN, Harms JF, Schmidt CJ: Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background. Neuropharmacology 2008;54:417–427.
- Menniti FS, Chappie TA, Humphrey JM, Schmidt CJ: Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophrenia. Curr Opin Investig Drugs 2007;8:54–59.
- Schmidt CJ, Chapin DS, Cianfrogna J, et al: Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia. J Pharmacol Exp Ther 2008;325:681–690.
- Chappie T, Humphrey J, Menniti F, Schmidt C: PDE10A inhibitors: an assessment of the current CNS drug discovery landscape. Curr Opin Drug Discov Devel 2009;12:458–467.
- Engel L, Mathes A, Schwerdtle I, Heinrich B, Pogorzelski B, Holthues H, Vollrath L, Spessert, R: Rat pineal arylalkylamine N-acetyltransferase: cyclic AMP inducibility of its gene depends on prior entrained photoperiod. Mol Brain Res 2004;123:45–55.
- Lentz M: Time series analysis-Cosinor analysis: a special case. West J Nurs Res 1990;12:408–412.
- Spiwoks-Becker I, Maus C, Tom Dieck S, Fejtová A, Engel L, Wolloscheck T, Wolfrum U, Vollrath L, Spessert R: Active zone proteins are dynamically associated with synaptic ribbons in rat pinealocytes. Cell Tissue Res 2008;333:185–195.
- Spessert R, Gupta BBP, Rohleder N, Gerhold S, Engel L: Cyclic AMP-inducible genes respond uniformly to seasonal lighting conditions in the rat pineal gland. Neuroscience 2006;143:607–613.
- Klein DC, Sugden D, Weller JL: Postsynaptic alpha-adrenergic receptors potentiate the beta-adrenergic stimulation of pineal serotonin N-acetyltransferase. Proc Natl Acad Sci USA 1983;80:599–603.
-
Siuciak JA, Chapin DS, Harms JF, Lebel LA, McCarthy SA, Chambers L, Shrikhande A, Wong S, Menniti FS, Schmidt CJ: Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis Neuropharmacology 2006b;51:386–396.
- Wolloscheck T, Spiwoks-Becker I, Rickes O, Holthues H, Spessert R: Phosphodiesterase 10A: abundance and circadian regulation in the retina and photoreceptor of the rat. Brain Res 2011;1376:42–50.
- Klein DC, Bailey MJ, Carter DA, Kim JS, Shi Q, Ho AK, Chik CL, Gaildrat P, Morin F, Ganguly S, Rath MF, Møller M, Sugden D, Rangel ZG, Munson PJ, Weller JL, Coon SL: Pineal function: impact of microarray analysis. Mol Cell Endocrinol 2010;314:170–183.
- Kotera J, Sasaki T, Kobayashi T, Fujishige K, Yamashita Y, Omori K: Subcellular localization of cyclic nucleotide phosphodiesterase type 10A variants, and alteration of the localization by cAMP-dependent protein kinase-dependent phosphorylation. J Biol Chem 2004;279:4366–4375.
- Schaad NC, Vanecek J, Schulz PE: Photoneural regulation of rat pineal nitric oxide synthase. J Neurochem 1994;62:2496–2499.
- Spessert R, Layes E, Schollmayer A, Reuss S, Vollrath L: In the rat pineal gland, but not in the suprachiasmatic nucleus, the amount of constitutive neuronal nitric oxide synthase is regulated by environmental lighting conditions. Biochem Biophys Res Commun 1995;212:70–76.
- Foulkes NS, Duval G, Sassone-Corsi P: Adaptive inducibility of CREM as transcriptional memory of circadian rhythm. Nature 1996;381:83–85.
- Maronde E and Stehle JH: The mammalian pineal gland: known facts, unknown facets. Trends Endocrinol Metab 2007;18:142–149.
- Nishi A, Kuroiwa M, Miller DB, O’Callaghan JP, Bateup HS, Shuto T, Sotogaku N, Fukuda T, Heintz N, Greengard P, Snyder GL: Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 2008;28:10460–10471.
Article / Publication Details
First-Page Preview
Received: October 22, 2010
Accepted: March 05, 2011
Published online: April 07, 2011
Issue release date: September 2011
Number of Print Pages: 11
Number of Figures: 6
Number of Tables: 1
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
